ULCID Capsules Gastro-Resistant 20 Milligram

Country: Ireland

Language: English

Source: HPRA (Health Products Regulatory Authority)

Buy It Now

Active ingredient:

OMEPRAZOLE

Available from:

Astellas Pharma Co. Ltd

Dosage:

20 Milligram

Pharmaceutical form:

Capsules Gastro-Resistant

Authorization date:

2006-04-28

Summary of Product characteristics

                                SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Ulcid 20 mg gastro-resistant capsules
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
One capsule contains 20 mg of omeprazole.
Excipient:
Each gastro-resistant capsule contains 116mg lactose monohydrate.
For a full list of excipients, see 6.1.
3 PHARMACEUTICAL FORM
Gastro-resistant capsules, hard (capsule)
Opaque, white hard capsules marked with imprint '20' on the body and 'OM' on the cap. The capsules contain gastro-
resistant microtablets.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
Ulcid gastro-resistant capsules are indicated for:
Adults:
o
Treatment of duodenal ulcers
o
Prevention of relapse of duodenal ulcers
o
Treatment of gastric ulcers
o
Prevention of relapse of gastric ulcers
o
In combination with appropriate antibiotics, Helicobacter pylori (H. pylori) eradication in peptic ulcer disease
o
Treatment of NSAID- associated gastric and duodenal ulcers
o
Prevention of NSAID–associated gastric and duodenal ulcers in patients at risk
o
Treatment of reflux oesophagitis
o
Long-term management of patients with healed reflux esophagitis
o
Treatment of symptomatic gastro-oesophageal reflux disease
o
Treatment of Zollinger-Ellison syndrome
Paediatric use
_Children over 1 year of age and_
_10 kg_
o
Treatment of reflux esophagitis
o
Symptomatic treatment of heartburn and acid regurgitation in gastro-esophageal reflux disease
_Children and adolescents over 4 years of age_
o
In combination with antibiotics in treatment of duodenal ulcer caused by H. pylori
IRISH MEDICINES BOARD
________________________________________________________________________________________________________________________
_Date Printed 16/03/2012_
_CRN 2091617_
_page number: 1_
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
Posology in Adults
_Treatment of duodenal ulcers_
The recommended dose i
                                
                                Read the complete document